N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress
Authors:
- Mario G MorenoMMMario G Moreno
- Pablo MurielPMPablo Muriel
- 1 August 2009
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 21 (8) , 908-914
Abstract
Objectives N-acetylcysteine (NAC) is an antioxidant, a precursor of reduced glutathione, and an inhibitor of the profibrotic cytokine liver transforming growth factor-beta (TGF-β). Carbon tetrachloride (CCl4) cirrhosis is characterized by oxidative stress and fibrosis. Therefore, the aim of this work was to study the effect of NAC on experimental cirrhosis. Methods CCl4 was chronically administered for 8 weeks along with 300 mg/kg of NAC orally once a day. Alkaline phosphatase, alanine aminotransferase, and γ-glutamyltranspeptidase were measured in plasma. Hydroxyproline, glycogen, lipid peroxidation, glutathione were determined in liver samples by colorimetric methods. TGF-β was evaluated by western blotting, and a histopathological analysis was performed. Results Serum markers of liver damage increased by CCl4 intoxication (PPPP4 (PP4 group (PP4, NAC cotreatment abolished TGF-β signal (P<0.05). Conclusion Our results strongly suggest that NAC prevents experimental cirrhosis by two mechanisms: by preventing oxidative stress and by downregulating the profibrogenic cytokine TGF-β. As NAC is currently used in humans intoxicated with paracetamol, it can be tested in fibrotic or cirrhotic patients under controlled trials.Keywords
This publication has 30 references indexed in Scilit:
- Common and unique mechanisms regulate fibrosis in various fibroproliferative diseasesJournal of Clinical Investigation, 2007
- N‐Acetyl‐L‐Cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF‐β signallingJournal of Cellular and Molecular Medicine, 2006
- N-Acetyl-l-cysteine suppresses TGF-β signaling at distinct molecular steps: The biochemical and biological efficacy of a multifunctional, antifibrotic drugBiochemical Pharmacology, 2005
- Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N -acetylcysteine rescuePediatric Blood & Cancer, 2005
- Effects of N-acetylcysteine Treatment on Oxidative Stress in Acetic Acid-induced Experimental Colitis in RatsJournal of International Medical Research, 2005
- Protective effect of N-acetylcysteine against oxygen radical-mediated coronary artery injuryBrazilian Journal of Medical and Biological Research, 2004
- Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in ratsJournal of Gastroenterology, 2004
- Type I procollagen production and cell proliferation is mediated by transforming growth factor-beta in a model of hepatic fibrosis.Endocrinology, 1996
- N-acetyl-l-cysteineJournal of Cellular Biochemistry, 1993
- A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic TransaminasesAmerican Journal of Clinical Pathology, 1957